Trial intelligence / Profile preview

Butorphanol and early postoperative cognitive function after thoracoscopic surgery in elderly patients

ChiCTR2100052350Phase 4Not yet recruiting

Sponsor
The First Affiliated Hospital of Guangxi Medical University
Start
Oct 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of butorphanol in lung neoplasm (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoints: Mini-Mental State Examination (MMSE), Visual Analog Scale (VAS) pain score and 1 more. Planned start Oct 2021; status: not yet recruiting.

02

Drugs

butorphanol
03

Conditions

lung neoplasm

Beyond the preview

Go deeper on ChiCTR2100052350.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100052350.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call